IVIG for Guillain-Barré Syndrome from Canada
Intravenous immunoglobulin pooled from thousands of donors, used therapeutically for Guillain-Barré and other neuropathies. Falls under HTS 3002.12.0090 as modified blood fraction immunological product. Bioprocessing includes pathogen reduction for safety.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Pool donor serology and IgG subclass profiles in import dossier